1.Persons who do not meet the selection criteria2.Persons who have been infected with SARS-CoV-2 within 3 months3.Persons who have had close contact with SARS-CoV-2 infected persons within 2 weeks4.Persons who are taking Camostat Mesilate tablets due to chronic pancreatitis, etc.5.Persons who are at risk of developing allergies related to this study6.Persons with symptoms such as fever, sore throat, cough, dysgeusia, olfactory sensation, and diarrhea within 3 weeks7.Persons who are currently participating in some clinical trial or who participated within 2 months before the start of the trial8.Persons who are judged to be unsuitable by the principal investigator and the investigators

1.Persons who do not meet the selection criteria2.Persons who have been infected with SARS-CoV-2 within 3 months3.Persons who have had close contact with SARS-CoV-2 infected persons within 2 weeks4.Persons who are taking Camostat Mesilate tablets due to chronic pancreatitis, etc.5.Persons who are at risk of developing allergies related to this study6.Persons with symptoms such as fever, sore throat, cough, dysgeusia, olfactory sensation, and diarrhea within 3 weeks7.Persons who are currently participating in some clinical trial or who participated within 2 months before the start of the trial8.Persons who are judged to be unsuitable by the principal investigator and the investigators